Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection
- PMID:8903312
- PMCID: PMC507637
- DOI: 10.1172/JCI118998
Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection
Abstract
It has been suggested that entry of pathogenic bacteria, including streptococci, into epithelial cells may represent an early stage of invasive infections. We found that poorly encapsulated wild-type strains and unencapsulated mutants of group A Streptococcus entered cultured human keratinocytes with high efficiency, while strains that produced large amounts of hyaluronic acid capsule did not, regardless of M-protein type or clinical source of the isolate. However, encapsulated streptococci produced extensive local necrosis and systemic infection in a mouse model of skin infection, while an isogenic acapsular strain did not. The results implicate the hyaluronic acid capsule as a virulence factor in soft tissue infection. Entry of poorly encapsulated group A Streptococcus into human epithelial cells does not appear to represent an initial step in invasive disease; rather, the capacity of encapsulated strains to avoid uptake by epithelial cells is associated with enhanced virulence in skin and soft tissue infection.
Similar articles
- Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.Ashbaugh CD, Warren HB, Carey VJ, Wessels MR.Ashbaugh CD, et al.J Clin Invest. 1998 Aug 1;102(3):550-60. doi: 10.1172/JCI3065.J Clin Invest. 1998.PMID:9691092Free PMC article.
- Role of group A streptococcal virulence factors in adherence to keratinocytes.Darmstadt GL, Mentele L, Podbielski A, Rubens CE.Darmstadt GL, et al.Infect Immun. 2000 Mar;68(3):1215-21. doi: 10.1128/IAI.68.3.1215-1221.2000.Infect Immun. 2000.PMID:10678929Free PMC article.
- Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes.Schrager HM, Albertí S, Cywes C, Dougherty GJ, Wessels MR.Schrager HM, et al.J Clin Invest. 1998 Apr 15;101(8):1708-16. doi: 10.1172/JCI2121.J Clin Invest. 1998.PMID:9541502Free PMC article.
- The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.Stollerman GH, Dale JB.Stollerman GH, et al.Clin Infect Dis. 2008 Apr 1;46(7):1038-45. doi: 10.1086/529194.Clin Infect Dis. 2008.PMID:18444821Review.
- Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis.Flores AR, Jewell BE, Fittipaldi N, Beres SB, Musser JM.Flores AR, et al.mBio. 2012 Nov 6;3(6):e00413-12. doi: 10.1128/mBio.00413-12.mBio. 2012.PMID:23131832Free PMC article.Review.
Cited by
- Role of NADase in virulence in experimental invasive group A streptococcal infection.Bricker AL, Carey VJ, Wessels MR.Bricker AL, et al.Infect Immun. 2005 Oct;73(10):6562-6. doi: 10.1128/IAI.73.10.6562-6566.2005.Infect Immun. 2005.PMID:16177331Free PMC article.
- Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae.Morona JK, Morona R, Miller DC, Paton JC.Morona JK, et al.J Bacteriol. 2003 May;185(10):3009-19. doi: 10.1128/JB.185.10.3009-3019.2003.J Bacteriol. 2003.PMID:12730159Free PMC article.
- A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes.Cue D, Southern SO, Southern PJ, Prabhakar J, Lorelli W, Smallheer JM, Mousa SA, Cleary PP.Cue D, et al.Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2858-63. doi: 10.1073/pnas.050587897.Proc Natl Acad Sci U S A. 2000.PMID:10706638Free PMC article.
- Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements.Falaleeva M, Zurek OW, Watkins RL, Reed RW, Ali H, Sumby P, Voyich JM, Korotkova N.Falaleeva M, et al.Infect Immun. 2014 Dec;82(12):5293-307. doi: 10.1128/IAI.02035-14. Epub 2014 Oct 6.Infect Immun. 2014.PMID:25287924Free PMC article.
- Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulence.Gupta R, Yang J, Dong Y, Swiatlo E, Zhang JR, Metzger DW, Bai G.Gupta R, et al.Infect Immun. 2013 Oct;81(10):3903-11. doi: 10.1128/IAI.00778-13. Epub 2013 Aug 5.Infect Immun. 2013.PMID:23918778Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical